Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

hematological · Mechanism Report

Can MTHFD1 rs2236225 AA reduce red-cell DNA synthesis and raise MCV and RDW despite optimal serum folate?

The MTHFD1 rs2236225 AA genotype can impair red-cell DNA synthesis and is associated with higher MCV and RDW even when serum folate is optimal.

PlausibleJuly 20, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

MTHFD1 rs2236225 AA can reduce one-carbon throughput needed for red-cell DNA synthesis, aligning with above-optimal mean corpuscular volume and red cell distribution width despite optimal serum folate.

laying out figure…
1 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This claim says the rs2236225 AA genotype may lower cytosolic one-carbon flow needed for nucleotide production during erythropoiesis. The mechanism frames this as reduced MTHFD1 stability, which can limit DNA synthesis in developing red cells and produce macrocytic, more variable cell measurements. It also notes that these changes can appear despite normal serum folate because the issue is intracellular folate handling.

Verified conclusion

The MTHFD1 rs2236225 AA genotype represents a genetic variation in cytosolic one-carbon metabolism that directly impacts erythropoiesis and standard red blood cell markers.

Mechanistic pathways

  • Enzyme destabilization: The rs2236225 AA (R653Q) variant compromises the stability of the 10-formyl-THF synthetase domain of the trifunctional MTHFD1 enzyme. This variant exhibits increased sensitivity to TRIM21-mediated ubiquitination and subsequent proteasomal degradation.
  • Impaired nucleotide synthesis: The resulting reduction in enzyme stability limits the cytosolic flux of serine- and formate-derived one-carbon units. This bottleneck decreases the availability of 10-formyl-THF and methylene-THF, directly impairing de novo purine and thymidylate (dTMP) synthesis.
  • Erythroid DNA replication failure: Because rapidly dividing erythroid progenitors depend on a continuous supply of these nucleotide precursors, this metabolic bottleneck compromises DNA replication during red-cell development.

Clinical implications

  • Macrocytic indicators: Impaired DNA synthesis during erythropoiesis prevents normal cell division, leading to the formation of larger, irregular red blood cells. The AA genotype is clinically associated with macrocytosis (above-optimal Mean Corpuscular Volume, MCV) and anisocytosis (above-optimal Red Cell Distribution Width, RDW), particularly under metabolic stress.
  • Normal serum folate paradox: Because the genetic defect impairs intracellular folate processing and stability rather than systemic absorption, these elevated hematologic markers can persist despite optimal serum folate levels. Standard serum tests may mask a localized, functional folate deficiency in the bone marrow.

Bottom line

  • The MTHFD1 rs2236225 AA genotype destabilizes key enzymatic domains required for cytosolic one-carbon flux. This cellular bottleneck impairs red-cell DNA synthesis, explaining why individuals can exhibit elevated MCV and RDW indicative of functional folate deficiency even when circulating serum folate levels are completely optimal.

References

  1. Common Variants in One-Carbon Metabolism Genes ... — pmc.ncbi.nlm.nih.gov ↗
  2. [PDF] Genetic Variants in One-Carbon Metabolism and Their Effects on ... — pdfs.semanticscholar.org ↗
  3. Association of MTHFD1 G1958A (rs2236225) gene ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. MTHFD1 Gene and methylation and B-vitamin use - Metastate Bio — person.metastate.bio ↗
  5. Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesis | PNAS — pnas.org ↗
  6. The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growth — link.springer.com ↗
  7. The negative effect of G1958A polymorphism on MTHFD1 protein ... — pubmed.ncbi.nlm.nih.gov ↗
  8. MTHFD1 Gene: Role in Disease Susceptibility and Pharmacogenetics — tandfonline.com ↗
  9. Mthfd1 is an essential gene in mice and alters biomarkers of impaired one-carbon metabolism - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  10. Clinical research — archivesofmedicalscience.com ↗
  11. Doubly bi-allelic variants of MTHFR and MTHFD1 in a ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  12. Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele — ncbi.nlm.nih.gov ↗
  13. Polymorphisms in the one‐carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study — onlinelibrary.wiley.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible24 sourcesCan low folate and vitamin B12 impair homocysteine remethylation and cause macrocytic red-cell changes?→Plausible21 sourcesDoes vitamin B12 need folate for DNA synthesis and red blood cell maturation?→